EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.

EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.

Item
http://www.wikidata.org/entity/Q42252801
Impact of cyclooxygenase-2 and prostaglandin-E2 expression on clinical outcome after pulmonary metastasectomy.KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastasesHigh BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort.Association between KRAS mutation and lung metastasis in advanced colorectal cancer.KRAS mutation in lung metastases from colorectal cancer: prognostic implications.KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer.Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.Clinical impact of c-MET expression and mutational status in patients with colorectal cancer lung metastases.Increased lymphangiogenesis in lung metastases from colorectal cancer is associated with early lymph node recurrence and decreased overall survival.Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatmentPD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer.EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function.Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?Mutations of key driver genes in colorectal cancer progression and metastasis.Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer.
P2860

EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.

Item
http://www.wikidata.org/entity/Q42252801
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
EGFR, BRAF and KRAS status in ...... a prospective follow-up study.
@en
EGFR, BRAF and KRAS status in ...... a prospective follow-up study.
@nl
type
label
EGFR, BRAF and KRAS status in ...... a prospective follow-up study.
@en
EGFR, BRAF and KRAS status in ...... a prospective follow-up study.
@nl
prefLabel
EGFR, BRAF and KRAS status in ...... a prospective follow-up study.
@en
EGFR, BRAF and KRAS status in ...... a prospective follow-up study.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
EGFR, BRAF and KRAS status in ...... a prospective follow-up study
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698